Acrivon Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | — | $-16.2M | $-16.2M |
| FY2022 | — | $-32.7M | $-31.2M |
| FY2023 | — | $-67.1M | $-60.4M |
| FY2024 | — | $-89.2M | $-80.6M |
| FY2025 | — | $-84.1M | $-77.9M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | — | $-16.2M | $-16.2M |
| FY2022 | — | $-32.7M | $-31.2M |
| FY2023 | — | $-67.1M | $-60.4M |
| FY2024 | — | $-89.2M | $-80.6M |
| FY2025 | — | $-84.1M | $-77.9M |